Literature DB >> 12064087

Understanding the etiology of Stargardt's disease.

Liane Clamen Glazer1, Thaddeus P Dryja.   

Abstract

Stargardt's disease is a form of juvenille macular degeneration. Patients with Stargardt's disease typically present in the first or second decade of life, complaining of decreased visual acuity. Recent research allows for a three-step explanation of the pathophysiology of Stargardt's disease: 1) Defective Rim Protein, a protein encoded by the ABCA4 gene, causes an accumulation of protonated N-retinylidene-PE in the rod outer segments; 2) A2-E, a byproduct of N-retinylidene-PE, then accumulates in the RPE cells and is toxic to them; 3) Photoreceptors eventually die secondary to loss of the RPE support function. With our new knowledge of the etiology of Stargardt's disease, we can devise future studies directed at treating affected patients.

Entities:  

Mesh:

Year:  2002        PMID: 12064087     DOI: 10.1016/s0896-1549(01)00011-6

Source DB:  PubMed          Journal:  Ophthalmol Clin North Am        ISSN: 0896-1549


  19 in total

1.  Transition zones between healthy and diseased retina in choroideremia (CHM) and Stargardt disease (STGD) as compared to retinitis pigmentosa (RP).

Authors:  Margot A Lazow; Donald C Hood; Rithambara Ramachandran; Tomas R Burke; Yi-Zhong Wang; Vivienne C Greenstein; David G Birch
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-20       Impact factor: 4.799

Review 2.  Allelic and phenotypic heterogeneity in ABCA4 mutations.

Authors:  Tomas R Burke; Stephen H Tsang
Journal:  Ophthalmic Genet       Date:  2011-04-21       Impact factor: 1.803

3.  In vivo dark-field imaging of the retinal pigment epithelium cell mosaic.

Authors:  Drew Scoles; Yusufu N Sulai; Alfredo Dubra
Journal:  Biomed Opt Express       Date:  2013-08-23       Impact factor: 3.732

4.  Peripheral Visual Fields in ABCA4 Stargardt Disease and Correlation With Disease Extent on Ultra-widefield Fundus Autofluorescence.

Authors:  Maria Fernanda Abalem; Benjamin Otte; Chris Andrews; Katherine A Joltikov; Kari Branham; Abigail T Fahim; Dana Schlegel; Cynthia X Qian; John R Heckenlively; Thiran Jayasundera
Journal:  Am J Ophthalmol       Date:  2017-10-14       Impact factor: 5.258

Review 5.  Ceramide signaling in retinal degeneration.

Authors:  Hui Chen; Julie-Thu A Tran; Richard S Brush; Anisse Saadi; Abul K Rahman; Man Yu; Douglas Yasumura; Michael T Matthes; Kelly Ahern; Haidong Yang; Matthew M LaVail; Md Nawajes A Mandal
Journal:  Adv Exp Med Biol       Date:  2012       Impact factor: 2.622

6.  Retinal sphingolipids and their very-long-chain fatty acid-containing species.

Authors:  Richard S Brush; Julie-Thu A Tran; Kimberly R Henry; Mark E McClellan; Michael H Elliott; Md Nawajes A Mandal
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-04-14       Impact factor: 4.799

7.  Multimodal analysis of the Preferred Retinal Location and the Transition Zone in patients with Stargardt Disease.

Authors:  Tommaso Verdina; Vivienne C Greenstein; Andrea Sodi; Stephen H Tsang; Tomas R Burke; Ilaria Passerini; Rando Allikmets; Gianni Virgili; Gian Maria Cavallini; Stanislao Rizzo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-04-02       Impact factor: 3.117

8.  Retinal pigment epithelial cells promote spatial reorganization and differentiation of retina photoreceptors.

Authors:  Olga L German; Edgardo Buzzi; Nora P Rotstein; Enrique Rodríguez-Boulan; Luis E Politi
Journal:  J Neurosci Res       Date:  2008-12       Impact factor: 4.164

9.  Clinical phenotypes and prognostic full-field electroretinographic findings in Stargardt disease.

Authors:  Sarwar Zahid; Thiran Jayasundera; William Rhoades; Kari Branham; Naheed Khan; Leslie M Niziol; David C Musch; John R Heckenlively
Journal:  Am J Ophthalmol       Date:  2012-12-05       Impact factor: 5.258

10.  A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease.

Authors:  Nuno L Gomes; Vivienne C Greenstein; Joshua N Carlson; Stephen H Tsang; R Theodore Smith; Ronald E Carr; Donald C Hood; Stanley Chang
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.